pemigatinib

Spain

Drugs containing this active substance

  • PEMAZYRE 13.5 MG TABLETS

    It is used to treat adults with bile duct cancer (cholangiocarcinoma) who have an abnormal form of the FGFR2 protein, especially when the cancer has spread to other parts of the body, cannot be operated on, or when other treatments no longer work.

    Form: tablets

    Active substance Dosage
    pemigatinib 13,5 mg

    ATC: L01E L01EN L01EN02

    Manufacturer: Incyte Biosciences Distribution B.V.

  • It is used to treat adults with bile duct cancer (cholangiocarcinoma) whose cancer cells have an abnormal form of the FGFR2 protein, especially when the cancer has spread to other parts of the body, cannot be removed by surgery, or when other treatments are no longer effective.

    Form: tablets

    Active substance Dosage
    pemigatinib 4,5 mg

    ATC: L01E L01EN L01EN02

    Manufacturer: Incyte Biosciences Distribution B.V.

  • It is used to treat adults with bile duct cancer (cholangiocarcinoma) whose cancer cells have an abnormal form of the FGFR2 protein, especially when the cancer has spread to other parts of the body, cannot be removed by surgery, or when other treatments are no longer effective.

    Form: tablets

    Active substance Dosage
    pemigatinib 9 mg

    ATC: L01E L01EN L01EN02

    Manufacturer: Incyte Biosciences Distribution B.V.